
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials
Kidney disease: Proton Intelligence raises $6.95M for potassium monitoring trials Proton Intelligence Inc., the developer of the innovative Continuous Potassium Monitoring (CKM™) platform, has successfully closed a $6.95 million USD…